Global Stem Cell Assay market was valued approximately USD 540 million in 2016, is anticipated to grow 1580 million by 2025. The market has witnessed a significant growth in investments from research institution and biotechnology companies across the world. Moreover, rising prevalence of Cancer and Chronic diseases has compelled the innovations in the market. 
Assay:

§ Cell Viability & Toxicity Assays
§ Isolation/Purification Assays
§ Cell Identification Assays
§ Cell Proliferation Assays
§ Cell Differentiation Assays
§ Cell Function Assays
§ Cell Apoptosis Assays

Kits:
§ Adult Stem Cell Kits
o Mesenchymal Stem Cell Kits
o Induced Pluripotent Stem Cell Kits
o Hematopoietic Stem Cell Kits
o Neuronal Stem Cells Kits
o Umbilical Cord Stem Cells
§ Human Embryonic Stem Cells Kits

Product:
§ Instruments
o Micro Electrode Arrays
o Flow Cytometer
o Cell Imaging Systems
o Automated Cell Counter
§ Detection Kits

Application:
§ Regenerative Medicine & Therapy Development
§ Drug Discovery and Development
§ Clinical Research

Regions:
§ North America
o U.S.
o Canada
§ Europe
o UK
o Germany
o France
§ Asia Pacific
o China
o India
o Japan
§ Rest of the World

Drug discovery and development application hold the largest share of approx. 38% in 2016. However, regenerative medicine and therapy development application are expected to grow at highest CAGR during the forecast period. This area of application is expected to receive a significant amount of government and private funding in coming years, thus expected to witness accelerated growth.   
Regionally, global stem cell assay market is segmented into North America, APAC, Europe & Rest of the World (RoW). The report further provides a detailed analysis of countries under each of the mentioned regions.  Globally, in 2016, North America accounted the largest revenue share of 40 %( approx) in the market. However, with rising healthcare expenditure and development of healthcare infrastructure, Asian countries are expected to witness increasing research activities in coming years. Thus,  Asia Pacific stem cell assay market is expected to grow at highest CAGR during the forecast period 2017-2025.
The competitive landscape of Stem Cell Assay market is expected to soon witness rising interest of many pharmaceutical companies as well. However, currently many biotechnology companies are leading the market space. The report offers a detailed orientation of leading companies and their key strategies. Some of the key players discussed in the report include GE Healthcare, Promega Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Cell Biolabs, Inc., Hemogenix Inc., STEMCELL Technologies Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, and Cellular Dynamics International, Inc.